−5.6609USD
−18.85 MUSD
10.14 M
About CNS Pharmaceuticals, Inc.
Sector
CEO
John M. Climaco
Headquarters
Houston
Website
Employees (FY)
5
Founded
2017
ISIN
US18978H2013
FIGI
BBG00PM24T16
CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CNSP is 0.2020 USD — it has decreased by 0.98% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange CNS Pharmaceuticals, Inc. stocks are traded under the ticker CNSP.
CNS Pharmaceuticals, Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
CNSP stock is 13.81% volatile and has beta coefficient of 0.46. Check out the list of the most volatile stocks — is CNS Pharmaceuticals, Inc. there?
CNSP earnings for the last quarter are −1.04 USD per share, whereas the estimation was −2.82 USD resulting in a 63.12% surprise. The estimated earnings for the next quarter are −1.73 USD per share. See more details about CNS Pharmaceuticals, Inc. earnings.
Yes, you can track CNS Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
CNSP stock has fallen by 14.41% compared to the previous week, the month change is a 43.02% fall, over the last year CNS Pharmaceuticals, Inc. has showed a 90.56% decrease.
CNSP net income for the last quarter is −5.38 M USD, while the quarter before that showed −4.52 M USD of net income which accounts for −18.85% change. Track more CNS Pharmaceuticals, Inc. financial stats to get the full picture.
Today CNS Pharmaceuticals, Inc. has the market capitalization of 2.17 M, it has decreased by 8.10% over the last week.
No, CNSP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CNSP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CNS Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 5.00 employees. See our rating of the largest employees — is CNS Pharmaceuticals, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CNS Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CNS Pharmaceuticals, Inc. stock shows the sell signal. See more of CNS Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.